Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Air Products & Chemicals, Inc. (APD) vs Novo Nordisk A/S (NVO) Price & Performance

Air Products & Chemicals, Inc.Trade
Novo Nordisk A/STrade

Price performance (Past 24H)

Key statistics

Air Products & Chemicals, Inc. vs Novo Nordisk A/S — how do they compare? Air Products & Chemicals, Inc. trades at $308.56 (market cap $68.63B), while Novo Nordisk A/S trades at $45.87 (market cap $207.31B). The key difference: Novo Nordisk A/S is far larger — about 3× Air Products & Chemicals, Inc.'s market cap, and Novo Nordisk A/S pays the higher dividend (3.76%). Which is the better fit depends on your goals.

APDNVO
Market Cap
$68.63B$207.31B
Sector
Basic MaterialsHealth
52-Week High
$314.19$63.98
52-Week Low
$230.42$35.29
Enterprise Value
$85.80B$222.02B
Dividend Yield
2.35%3.76%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Air Products & Chemicals, Inc.

Air Products and Chemicals (APD) trades at $303.44, up 1.17% today, with a bullish technical outlook supported by moving averages and recent earnings beats. The stock shows strong analyst support with a consensus price target of $346, though high valuation ratios like a P/E of 30.86 and EV/EBITDA of 50.36 raise concerns. Recent news highlights a major semiconductor supply deal in Taiwan and raised guidance after Q3 2026 results.

The outlook is mixed: positive momentum from contract wins and earnings performance offers upside, but negative net income margins and elevated debt levels pose risks. Investors should weigh growth catalysts against financial leverage and profitability challenges.

Novo Nordisk A/S

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Air Products & Chemicals, Inc.

Since its founding in 1940, Air Products has become one of the leading industrial gas suppliers globally, with operations in 50 countries and 19,000 employees. The company is the largest supplier of hydrogen and helium in the world. It has a unique portfolio serving customers in a number of industries, including chemicals, energy, healthcare, metals, and electronics. Air Products generated $10.3 billion in revenue in fiscal 2021.

Read more on APD

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Read more on NVO